Nektar Therapeutics (NKTR) Update / Briefing June 24, 2025 08:15 AM ET Speaker0 Good morning, and thank you for joining the Nectar conference call to review the sixteen week induction data for the Phase IIb study of Rezpeg in patients with atopic dermatitis. At this time, all attendees are in a listen only mode. A question and answer session will follow the formal presentation. To our analysts that are joining us live to ask a question, please use the raise hand feature to indicate you have one. As a remind ...